Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Now I wait a whole year to get some information about what Ekimas is or should be. I wait for many months for the announced and further reports. And I wait two and a half months for a reply to my email to the company.
We are still shareholders and gave our money to the company.
I read that German text. I suspect that this is not an original since it sounds really wooden, not of the quality a journalist would write and even some words are used in a way a native speaker wouldn't do. Perhaps the writer had a really poor day but I have the feeling it was translated by some software. I was not able to find a potential original.
I didn't notice this until now: Recent 10-K is the first one with this address just on the first page above Swiss address:
c/o Ernie Stern
1101 Pennsylvania Avenue, N.W., Suite 300
Washington D.C.
United States
This address is also shown at otcmarkets.com: https://www.otcmarkets.com/stock/MYMX/profile
Again I wonder why.
Oh Mr. Kempers, since 26th of January we are suffering all day long, day after day. At that time you said "We’re now coming to the end of two animal studies[...]". What did the animals say? Did they stay healthy, did they keep strong upper arms? I hope they didn't make use of their right to remain silent.
From a high in February we lost half the value of our shares (and unfortunately I bought some more before the 10-Q came out). That's so depressing for my trading account.
I don't see a trade at 0.21. Just a bid of 0.30 currently.
Disappointing!
Mr. 10M you are on the right way but 0.0012 is too little.
You are probably right. But nevertheless shorting such a stock is daring because who knows if Mr. Walker really does nothing. EIPC could overnight be at 100x current share price. The only people who could know that is Mr. Walker himself or persons close to him. But even if such a person would be the one playing here, he/she can never know if some crazy crowd decides to run these shares up.
I would never short such a stock, but I don't like shorting at all.
I don't believe my eyes: 10,150,000 on bid. That's almost 4% of shares.
I still don't really understand what's going on with share and option count.
But now I am pretty sure that Mr. Kempers' 1 million options expired and he did not execute!
If you like, compare 2019 10-K page 73 to 2020 10-K page 78. In the older one you'll find 1 million options exerciseable at $0.19 expiring within 0.5 years. They are dropped in the 2020 10-K - that's stated clearly, but without a hint who was the owner. Executing options at 19 cents while share price is significanty lower obviously makes no sense.
But in total there seem to be lots of mistakes in the filings. E.g. execution price range is not correct and remaining life is not correct.
It seems to me that Mr. Kempers now has 2.8 years left to execute most of his options. Probably the most of them if not all have an execution price of 0.02; there's enough space in regard of current share price to execute and sell.
But again: I don't understand the change in the OTCQB Certification. Was it simply a correction or did something change?
New OTCQB Certification out.
Public float increased from 79,563,585 to 91.213,998. Wondering where such a quantity can come from without filing.
Mr. Kempers now owns 1 million shares less but there was also no filing about a sale.
Do you have any reference for that?
From time to time I see a sell order about 5,200,000 shares. Fake?
They or someone checked an old filing. There should be a reason for doing so. A buyer probably would find such mistakes.
That could be a reason for me to buy some more shares if there's an opportunity.
I don't understand this:
Thanks. The same to you!
If we see no 10-K until next week's Wednesday I will consider the possibility that there are talks about a takeover.
You possibly will have to absorb a great amount of shares if there's nothing in the 10-K because the sentiment seems very bullish to me. Many shareholders are expecting big things to come and the 10-K (due next week Wednesday) is the place that should be announced - at least as subsequent event. I suppose the disappointment will be big.
Sorry, but my guess is: If there was anything to report we would have seen it already and Mr. Kempers is again simply waiting to release the next report (10-K, next week) with nothing but the usual statements about ongoing projects, and immediately after that release share price will probably crash to 0.07. That will hurt me.
There's only one glimmer of hope: He didn't PR anything because he is negotiating about a takeover.
I know nothing, just as always. Therefore I could sell as well as buy, or hold. Or go and eat something and wait.
There's nothing like the word "will" (future) in the German text. It says it does (immune protection) and is meant to (prevent transmission).
Unfortunately I have to admit that you are probably right. The only "asset" EIPC seems to have is the "Retained earnings" of about $(5) million.
When diluting that much the company should have put out somthing about it's progress.
On 26th of January I sent an email to dw957445@gmail.com.
Probably Mr. Walker received the email since there was no delivery failure like for a non existent email address or a full mailbox. Nevertheless he didn't reply until today.
At least for instance at facebook he could drop a line in lack of a working website to show investors that he is at least looking for a way to sell as a shell or whatever.
As far as I know that information does not reflect short interest. You may read https://pubcoceo.com/2018/11/15/overview-short-selling-microcap-stocks-on-the-otc-markets/
Thanks. I hope the reason is indeed to optimize and not to correct deficiencies.
Unfortunately that purpose of use is very blurred.
I am not a chemist. Therefore I can't estimate what they could need $6 million for if the process is already working. Does it make sense for the big owners to increase share count from 216 million to 291 or even 373 million to get that money? If the CHS samples are good, in a half year CRTG could sell that much CHS that they could take these $6 million from the profit. Just wondering about the reasons...
I wonder if yesterday's news is positive or negative.
- Someone is willing to give CRTG much money but gets a really big stake at a very low share price.
- The company needs the money but do they need it to survive or to finance production of CHS for customers?
News: https://www.otcmarkets.com/stock/CRYO/news/story?e&id=1821584
Perhaps the reason for recent price incline.
I am wondering what's going on. There seem to be no remarkable news, but to be frank I were a bit lazy and didn't read the 10-Q from last Tuesday.
Thanks. A few PRs would be fine as well. Let's hope so.
No reply to my email sent to Mr. Kempers for a whole week.
Again two Form 4.
I would like to point to footnote (1) in the filings. The sales are not direct but indirect from Mr. Keen and Mr. Calton. The shares were held by a company called Carlton James Ltd. and obviously Mr. Calton and Mr. Keen control the shares through that company. Carlton James Ltd. seems to still own 26995986 shares. I can't believe they plan to sell that amount in parts of tenth or hunderd thousands.
I really like it.
Thanks. I have no Level 2.
Today I sent an email to Mr. Kempers. Didn't get a reply until now. I am curious if I will get one.
Kind of a little disappointing today.
Don't you trust the filings?
According to the OTCQB Certification from 10/28/2020
Keen: 99,923,283
Calton: 28,235,844
Dombrowski: 3,664,720
Kraft: 0
Hoffman: 0
But I don't know who owns how many stock options.
@Staypositive1: To line
1: leak
2: no
3: busy/regulation
But who knows... Today I was on the point to send an email to Mr. Kempers but that's probably waste of time.
I like it but can't believe this happens without news leaking.
Two Form 4 today. I don't understand it: Why do Victor Keen and Simon Calton sell some thousand shares in open market while owning many million shares? Are they cleaning up a bit, preparing for uplisting?
I doubt main investors are interested in pushing share price and dilluting their stake. We should never forget that they own the most shares and we are just crumbs.
And perhaps they think it's not necessary to raise a meaningful amount of money.
I wouldn't be surprised if we get significant news in February. Remember liquidation of Anergis and their intellectual property. Unfortunately I never saw a financial report from them, but they probably had a lot of debt. So, how could they liquidate the company without selling intellectual property? If there wouldn't be debt and there were only one or a few owners intellectual property could be easily transferred to that resp. theses persons. But creditors wouldn't accept that - they want to get their share.
If Anergis was a company as I suppose, they sold the birch pollen project. And that means for Mymetics
a) owns the IP now
b) licensed it's part on that project for instance to Stallergenes Greer and have a fat bank account now
c) will be sold
d) something strange happens, but I can't believe so.
In my opinion everything is well. In the shareholder letter one can read "In early 2021 evaluation samples of CHS will ship to customers. As we have reported, we have ten (10) initial evaluation samples [...]". That's a clear statement. They have the CHS produced and in hands; meanwhile it should been received by the customers.
One can also read "In fact, we have already asked Evonik for more CHS samples as demand has exceeded our initial expectations.". I think they wouldn't ask (and pay!) for more if Evonik couldn't produce big quantities.
I roughly doubled my share count recently.
Unfortunately without any information about financials:
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Extends-Its-Licensing-Agreement-with-NanoSmart-Pharmaceuticals-Inc-for-Human-Oncology?id=288565
I read a bit. It seems to me it's not possible to draw a conclusion from the timing of publicstions.